Lumigan and Olanzapine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lumigan (bimatoprost) and Olanzapine (olanzapine). Common drug interactions include gait disturbance among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Lumigan and Olanzapine. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Lumigan?

Lumigan has active ingredients of bimatoprost. It is often used in glaucoma. eHealthMe is studying from 20,478 Lumigan users. Check the latest studies of Lumigan.

What is Olanzapine?

Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.

On Jul, 15, 2026

22 people who take Lumigan and Olanzapine together, and have interactions are studied.

Lumigan and Olanzapine drug interactions.

What are the common drug interactions of Lumigan and Olanzapine, by gender? *:

female:

Gait disturbance
Arthralgia (joint pain)
Back pain
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Fall
Osteoporosis (bones weak and more likely to break)
Pneumonia
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Back injury
Balance disorder

male:

Arthralgia (joint pain)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Acute myocardial infarction (acute heart attack)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Cough
Dementia (madness)
Dysphagia (a condition in which swallowing is difficult or painful)
Fall
Head injury

What are the common drug interactions of Lumigan and Olanzapine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Arthralgia (joint pain)
Gait disturbance

30-39:

n/a

40-49:

n/a

50-59:

Alcohol poisoning
Alcoholism (problems with alcohol)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Arthropathy
Asthma
Breast cancer
Completed suicide (act of taking one's own life)
Diplopia (double vision)
Dry eye (lack of adequate tears)
Eye irritation

60+:

Fall
Arthralgia (joint pain)
Dysstasia (difficulty in standing)
Fatigue (feeling of tiredness)
Gait disturbance
Headache (pain in head)
Hip arthroplasty
Hypersomnia (excessive daytime sleepiness (eds))
Joint injury
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 8 people, 36.36%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 13.64%
High Blood Pressure: 3 people, 13.64%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 13.64%
Pain: 2 people, 9.09%
Nausea (feeling of having an urge to vomit): 2 people, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.09%
High Blood Cholesterol: 2 people, 9.09%
Herpes Zoster: 2 people, 9.09%
Diarrhea: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lumigan and Olanzapine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously